A study of immunohistochemical and electron microscopic changes in Dowling-Degos disease

Journal of Dermatology

Volumn 32, Issue 1, 2005, Pages 12-18

  Zhang, Ru Zhi ^a   Zhu, Wen Yuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Dowling Degos disease; Immunohistochemistry; Melanocyte; Transmission electron microscopy

Indexed keywords

CELL PROTEIN; MELANOSOMAL PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; MONOCLONAL ANTIBODY NKI; MONOCLONAL ANTIBODY PEP1; MONOCLONAL ANTIBODY PEP2; MONOPHENOL MONOOXYGENASE; PHOSPHOENOLPYRUVATE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CELL MATURATION; CYTOPLASM; DENDRITE; DIAGNOSTIC VALUE; DOWLING DEGOS DISEASE; ELECTRON MICROSCOPY; FEMALE; GENODERMATOSIS; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOSOME; MITOCHONDRION; SKIN BIOPSY;

EID: 14644441731     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00706.x     Document Type: Article

References (12)

1. Kushimoto T, Basrur V, Valencia J, et al: A model for melanosome biogenesis based on the purification and analysis of early melanosomes, Proc Natl Acad Sci USA, 98: 10698-10703, 2001.
2. Jimbow K, Ishida O, Ito S, Hori Y, Witkop CJ, King RA: Combined chemical and electron microscopic studies of pheomelanosomes in human red hair, J Invest Dermatol, 81: 506-511, 1983.
3. Crovato F, Nazzari G, Rebora A: Dowling-Degos disease (reticulate pigmented anomaly of the flexures) is an autosomal dominant condition, Br J Dermatol, 108: 473-476, 1983.
4. Kim YC, Davis MD, Scharbacher CF, et al: Dowling-Dego disease (reticulate pigmented s'nomaly of the flexures): a clinical and histopathologic study of 6 cases, J Am Acad Dermatol, 40: 462-467, 1999.
5. Ujihara M, Kamakura T, Ikeda M, Kodama H: Dowling-Degos disease associated with squamous cell carcinomas on the dappled pigmentation, Br J Dermatol, 147: 568-571, 2002.
6. Boissy RE: Melanosome transfor to and translocation in the keratinocyte, Exp Dermatol, 12 (suppl 2): 5-12, 2003.
7. Vennegoor C, Hagenman PH, Van Nouhuijs H, et al: A monoclonal antibody specific for cell of the melanocyte lineage, Am J Pathol, 130: 179-192, 1988.
8. Howell JB, Robert G, Freeman MD: Reticular pigmented anomaly of the flexures, Arch Dermal, 114:400-403, 1978.
9. Grosshans E, Geiger JM, Hanau D, Jelen G, Held E: Ultrastructure of early pigmentary changes in Dowling-Degos' disease, J Cutan Pathol, 7: 77-87, 1980.
10. Wakamatsu K, Ito S, Horikoshi T: Effects of melanogenesis-inducing nitric oxide and histamine on the production of eumelanin and pheomelanin in cultured human melanocytes, Pigment Cell Res, 16: 81-84, 2003.
11. Alaluf S, Atkins D, Barrett K, et al: Ethnic variation in melanin content and composition in photoexposed and photoprotected human skin, Pigment Cell Res, 15: 112-118, 2002.
12. Naysmith L, Waterston K, Ha T, et al: Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status, J Invest Dermatol, 122: 423-428, 2004.